GBI Research, the leading
business intelligence provider, has released its latest research:
"Critical Care Therapeutics in Major Developed Markets to 2020 - New and
Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market",
which provides in-depth analysis of the critical care market in the US, UK,
France, Germany, Italy, Spain, Japan and Canada. The report provides an
estimation of market size for 2013, along with market forecasts to 2020. It
covers critical care indications that are being treated using the five major
plasma-derived products of albumin, anti-thrombin concentrates, factor XIII
concentrates, fibrinogen concentrates, and prothrombin complex concentrates.
Browse
Full Report With TOC @ http://www.radiantinsights.com/research/critical-care-therapeutics-in-major-developed-markets-to-2020-new-and-late-stage-four-factor-pccs-and-recombinant-products-to-drive-market
The total value of the critical
care market in the major developed markets was estimated at $1.8 billion in
2013 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 4.7% to
$2.5 billion in 2019. This growth is attributed to the recent approval of new
factor concentrates in the US that are expected to witness increasing uptake in
the forecast period. Factor concentrates are increasingly preferred due to
their lower infection risks over older alternatives such as FFP and
cryoprecipitate in critical care settings.
The
US accounts for the largest share (41%) of the global critical care market and
is expected to post high growth at a CAGR of 7.5% until 2020. KCentra, the
first four-factor PCC in the US, and Tretten, the first recombinant FXIII
concentrate, were approved in 2013 and are expected to witness good uptake in
the forecast period. Two additional factor concentrates approved in the US in
2009 - RiaStap (human fibrinogen concentrate) and ATryn (recombinant AT
concentrate) - are also expected to increase their uptake, which will
contribute to market growth. With no new significant launches in the forecast
period, the European market is estimated to witness much slower growth, with
the UK at a CAGR of 3.0%, France at 2.5%, Germany and Spain both at 2.3%, and
Italy at 2.0%
About Radiant
Insights
Radiant
Insights is a platform for companies looking to meet their market research and
business intelligence requirements. We assist and facilitate organizations and
individuals procure market research reports, helping them in the decision
making process. We have a comprehensive collection of reports, covering over 40
key industries and a host of micro markets. In addition to over extensive
database of reports, our experienced research coordinators also offer a host of
ancillary services such as, research partnerships/ tie-ups and customized
research solutions.
For More
Information, Visit Radiant
Insights
Contact:
Michelle
Thoras
Corporate
Sales Specialist, USA
Radiant
Insights, Inc
Phone:
1-415-349-0054
Toll
Free: 1-888-202-9519
Email:
sales@radiantinsights.com
No comments:
Post a Comment